Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Other financing activities: 2016-2024

Historic Other financing activities for Mereo BioPharma Group (MREO) over the last 6 years, with Dec 2024 value amounting to $853,000.

  • Mereo BioPharma Group's Other financing activities fell 38.81% to $134,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $833,000, marking a year-over-year change of. This contributed to the annual value of $853,000 for FY2024, which is 66.93% up from last year.
  • Per Mereo BioPharma Group's latest filing, its Other financing activities stood at $853,000 for FY2024, which was up 66.93% from $511,000 recorded in FY2023.
  • Mereo BioPharma Group's Other financing activities' 5-year high stood at $853,000 during FY2024, with a 5-year trough of $511,000 in FY2023.
  • Its 2-year average for Other financing activities is $682,000, with a median of $682,000 in 2023.
  • Data for Mereo BioPharma Group's Other financing activities shows a peak YoY surged of 66.93% (in 2024) over the last 5 years.
  • Over the past 2 years, Mereo BioPharma Group's Other financing activities (Yearly) stood at $511,000 in 2023, then surged by 66.93% to $853,000 in 2024.